Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.23 USD | -0.21% | +3.10% | +32.74% |
04/06 | Oppenheimer Raises Price Target on Crinetics Pharmaceuticals to $74 From $55, Maintains Outperform Rating | MT |
03/06 | Transcript : Crinetics Pharmaceuticals, Inc. - Special Call |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.74% | 373.24Cr | |
+55.70% | 5.57TCr | |
+41.08% | 3.99TCr | |
-5.39% | 3.96TCr | |
-5.56% | 2.82TCr | |
+16.46% | 2.63TCr | |
-20.56% | 1.89TCr | |
+33.03% | 1.22TCr | |
+25.85% | 1.21TCr | |
+2.72% | 1.21TCr |
- Stock Market
- Equities
- CRNX Stock
- News Crinetics Pharmaceuticals, Inc.
- Transcript : Crinetics Pharmaceuticals, Inc. - Special Call